New discoveries in the genetics and genomics of systemic juvenile idiopathic arthritis

References

• Packham JCHM. Long-term follow-up of 246 adults with juvenile idiopathic arthritis: functional outcome. Rheumatology (Oxford). 2002;41:1428–1435. doi: 10.1093/rheumatology/41.12.1428
   PubMed Web of Science ®Google Scholar
• Chhabra A, Robinson C, Houghton K, et al. Long-term outcomes and disease course of children with juvenile idiopathic arthritis in the ReACCh-out cohort: a two-centre experience. Rheumatology (Oxford). 2020 Dec 1;59(12):3727–3730. doi: 10.1093/rheumatology/keaa118
   PubMed Web of Science ®Google Scholar
• Giancane G, Muratore V, Marzetti V, et al. Disease activity and damage in juvenile idiopathic arthritis: methotrexate era versus biologic era. Arthritis Res Ther. 2019 Jul 8;21(1):168. doi: 10.1186/s13075-019-1950-7
   PubMedGoogle Scholar
• Petty RE, Southwood TR, Manners P, et al. International League of Associations for Rheumatology classification of juvenile idiopathic arthritis: second revision, Edmonton, 2001. J Rheumatol. 2004 Feb;31(2):390–392.
   PubMed Web of Science ®Google Scholar
• Nagai H, Kirino Y, Nakano H, et al. Elevated serum gasdermin D N-terminal implicates monocyte and macrophage pyroptosis in adult-onset Still’s disease. Rheumatology (Oxford). 2021 Aug 2;60(8):3888–3895. doi: 10.1093/rheumatology/keaa814
   PubMed Web of Science ®Google Scholar
• Schulert GS, Kessel C. Molecular pathways in the pathogenesis of systemic juvenile idiopathic arthritis. Rheum Dis Clin North Am. 2023 Nov;49(4):895–911. doi: 10.1016/j.rdc.2023.06.007
   PubMed Web of Science ®Google Scholar
• Henderson LA, Hoyt KJ, Lee PY, et al. Th17 reprogramming of T cells in systemic juvenile idiopathic arthritis. JCI Insight. 2020 Mar 26;5(6). doi: 10.1172/jci.insight.132508
   Web of Science ®Google Scholar
• Schulert GS, Yasin S, Carey B, et al. Systemic Juvenile Idiopathic Arthritis-Associated Lung disease: characterization and risk factors. Arthritis Rheumatol. 2019 Nov;71(11):1943–1954.
   PubMed Web of Science ®Google Scholar
• Saper VE, Chen G, Deutsch GH, et al. Emergent high fatality lung disease in systemic juvenile arthritis. Ann Rheum Dis. 2019 Dec;78(12):1722–1731.
   PubMed Web of Science ®Google Scholar
• Saper VE, Ombrello MJ, Tremoulet AH, et al. Severe delayed hypersensitivity reactions to IL-1 and IL-6 inhibitors link to common HLA-DRB1*15 alleles. Ann Rheum Dis. 2022 Mar;81(3):406–415. doi: 10.1136/annrheumdis-2021-220578
   PubMed Web of Science ®Google Scholar
• Aksentijevich I, Soriano A, Hernandez-Rodriguez JE. Editorial: autoinflammatory diseases: from genes to bedside. Front Immunol. 2020;11:1177. doi: 10.3389/fimmu.2020.01177
   PubMed Web of Science ®Google Scholar
• Lauschke VM, Milani L, Ingelman-Sundberg M. Pharmacogenomic biomarkers for improved drug therapy—recent progress and future developments. AAPS J. 2017 Nov 27;20(1):4.
   PubMed Web of Science ®Google Scholar
• Ombrello MJ, Arthur VL, Remmers EF, et al. Genetic architecture distinguishes systemic juvenile idiopathic arthritis from other forms of juvenile idiopathic arthritis: clinical and therapeutic implications. Ann Rheum Dis. 2017 May;76(5):906–913. doi: 10.1136/annrheumdis-2016-210324
   PubMed Web of Science ®Google Scholar
• Stock CJ, Ogilvie EM, Samuel JM, et al. Comprehensive association study of genetic variants in the IL-1 gene family in systemic juvenile idiopathic arthritis. Genes Immunity. 2008 Jun;9(4):349–357.
   PubMed Web of Science ®Google Scholar
• Hinks A, Martin P, Thompson SD, et al. Autoinflammatory gene polymorphisms and susceptibility to UK juvenile idiopathic arthritis. Pediatr Rheumatol Online J. 2013 Apr 2;11(1):14. doi: 10.1186/1546-0096-11-14
   PubMed Web of Science ®Google Scholar
• McDowell TL, Symons JA, Ploski R, et al. A genetic association between juvenile rheumatoid arthritis and a novel interleukin-1 alpha polymorphism. Arthritis Rheum. 1995 Feb;38(2):221–228.
   PubMedGoogle Scholar
• Donn RP, Barrett JH, Farhan A, et al. Cytokine gene polymorphisms and susceptibility to juvenile idiopathic arthritis. British paediatric rheumatology study group. Arthritis Rheum. 2001 Apr;44(4):802–810.
   PubMedGoogle Scholar
• Cinek O, Vavrincova P, Striz I, et al. Association of single nucleotide polymorphisms within cytokine genes with juvenile idiopathic arthritis in the Czech population. J Rheumatol. 2004 Jun;31(6):1206–1210.
   PubMed Web of Science ®Google Scholar
• Cimaz R, Cazalis MA, Reynaud C, et al. IL1 and TNF gene polymorphisms in patients with juvenile idiopathic arthritis treated with TNF inhibitors. Ann Rheumatic Dis. 2007;66(7):900–904. doi: 10.1136/ard.2006.067454
   PubMed Web of Science ®Google Scholar
• Fishman DFG, Mohamed-Ali R, Jeffery V, et al. The effect of novel polymorphisms in the interleukin-6 (IL-6) gene on IL-6 transcription and plasma IL-6 levels, and an association with systemic-onset juvenile chronic arthritis. J Clin Invest. 1998;102(7):1369–1376. doi: 10.1172/JCI2629
   PubMed Web of Science ®Google Scholar
• Ogilvie EM, Fife MS, Thompson SD, et al. The -174G allele of the interleukin-6 gene confers susceptibility to systemic arthritis in children: a multicenter study using simplex and multiplex juvenile idiopathic arthritis families. Arthritis Rheum. 2003 Nov;48(11):3202–3206.
   PubMed Web of Science ®Google Scholar
• Vencovsky J, Jarosova K, Ruzickova S, et al. Higher frequency of allele 2 of the interleukin-1 receptor antagonist gene in patients with juvenile idiopathic arthritis. Arthritis Rheum. 2001 Oct;44(10):2387–2391.
   PubMedGoogle Scholar
• Cimaz R, Cazalis MA, Reynaud C, et al. IL1 and TNF gene polymorphisms in patients with juvenile idiopathic arthritis treated with TNF inhibitors. Ann Rheum Dis. 2007 Jul;66(7):900–904.
   PubMed Web of Science ®Google Scholar
• Fife MS, Gutierrez A, Ogilvie EM, et al. Novel IL10 gene family associations with systemic juvenile idiopathic arthritis. Arthritis Res Ther. 2006;8(5):R148. doi: 10.1186/ar2041
   PubMed Web of Science ®Google Scholar
• Omoyinmi E, Forabosco P, Hamaoui R, et al. Association of the IL-10 gene family locus on chromosome 1 with juvenile idiopathic arthritis (JIA). PLOS ONE. 2012;7(10):e47673. doi: 10.1371/journal.pone.0047673
   PubMed Web of Science ®Google Scholar
• Donn R, Alourfi Z, De Benedetti F, et al. Mutation screening of the macrophage migration inhibitory factor gene: positive association of a functional polymorphism of macrophage migration inhibitory factor with juvenile idiopathic arthritis. Arthritis Rheum. 2002 Sep;46(9):2402–2409.
   PubMedGoogle Scholar
• Miterski B, Drynda S, Boschow G, et al. Complex genetic predisposition in adult and juvenile rheumatoid arthritis. BMC Genet. 2004 Feb 4;5(1):2. doi: 10.1186/1471-2156-5-2
   PubMedGoogle Scholar
• Berdeli A, Ozyurek AR, Ulger Z, et al. Association of macrophage migration inhibitory factor gene -173 G/C polymorphism with prognosis in Turkish children with juvenile rheumatoid arthritis. Rheumatol Int. 2006 Jun;26(8):726–731.
   PubMed Web of Science ®Google Scholar
• Bukulmez H, Fife M, Tsoras M, et al. Tapasin gene polymorphism in systemic onset juvenile rheumatoid arthritis: a family-based case-control study. Arthritis Res Ther. 2005;7(2):R285–90. doi: 10.1186/ar1480
   PubMed Web of Science ®Google Scholar
• Prahalad S, Bohnsack JF, Jorde LB, et al. Association of two functional polymorphisms in the CCR5 gene with juvenile rheumatoid arthritis. Genes Immunity. 2006 Sep;7(6):468–475.
   PubMed Web of Science ®Google Scholar
• Scheibel I, Veit T, Neves AG, et al. Differential CCR5Delta32 allelic frequencies in juvenile idiopathic arthritis subtypes: evidence for different regulatory roles of CCR5 in rheumatological diseases. Scand J Rheumatol. 2008 Jan;37(1):13–17.
   PubMed Web of Science ®Google Scholar
• Lindner E, Nordang GB, Melum E, et al. Lack of association between the chemokine receptor 5 polymorphism CCR5delta32 in rheumatoid arthritis and juvenile idiopathic arthritis. BMC Med Gene. 2007 Jun 12;8(1):33. doi: 10.1186/1471-2350-8-33
   PubMedGoogle Scholar
• Hinks A, Martin P, Flynn E, et al. Association of the CCR5 gene with juvenile idiopathic arthritis. Genes Immunity. 2010 Oct;11(7):584–589.
   PubMed Web of Science ®Google Scholar
• Border R, Johnson EC, Evans LM, et al. No support for historical Candidate gene or Candidate gene-by-interaction hypotheses for major depression across multiple large samples. Am J Psychiatry. 2019 May 1;176(5):376–387. doi: 10.1176/appi.ajp.2018.18070881
   PubMed Web of Science ®Google Scholar
• Farrell MS, Werge T, Sklar P, et al. Evaluating historical candidate genes for schizophrenia. Mol Psychiatry. 2015 May;20(5):555–562.
   PubMed Web of Science ®Google Scholar
• Ombrello MJ, Remmers EF, Tachmazidou I, et al. HLA-DRB1*11 and variants of the MHC class II locus are strong risk factors for systemic juvenile idiopathic arthritis. Proc Natl Acad Sci USA. 2015 Dec 29;112(52):15970–15975. doi: 10.1073/pnas.1520779112
   PubMed Web of Science ®Google Scholar
• Nigrovic PA. Autoinflammation and autoimmunity in systemic juvenile idiopathic arthritis. Proc Natl Acad Sci USA. 2015 Dec 29;112(52):15785–15786.
   PubMed Web of Science ®Google Scholar
• Kessel C, Hedrich CM, Foell D. Innately adaptive or truly autoimmune: is there something unique about systemic juvenile idiopathic arthritis? Arthritis Rheumatol. 2020 Feb;72(2):210–219. doi: 10.1002/art.41107
   PubMed Web of Science ®Google Scholar
• Prahalad S, Conneely KN, Jiang Y, et al. Brief report: susceptibility to childhood-onset rheumatoid arthritis: investigation of a weighted genetic risk score that integrates cumulative effects of variants at five genetic Loci. Arthritis Rheum. 2013 Jun;65(6):1663–1667.
   PubMedGoogle Scholar
• Hinks A, Cobb J, Marion MC, et al. Dense genotyping of immune-related disease regions identifies 14 new susceptibility loci for juvenile idiopathic arthritis. Nat Genet. 2013 Jun;45(6):664–669.
   PubMed Web of Science ®Google Scholar
• Arthur VL, Shuldiner E, Remmers EF, et al. IL1RN variation influences both disease susceptibility and response to recombinant human interleukin-1 receptor antagonist therapy in systemic juvenile idiopathic arthritis. Arthritis Rheumatol. 2018 Aug;70(8):1319–1330. doi: 10.1002/art.40498
   PubMed Web of Science ®Google Scholar
• Wakil SM, Monies DM, Abouelhoda M, et al. Association of a mutation in LACC1 with a monogenic form of systemic juvenile idiopathic arthritis. Arthritis Rheum. 2015;67(1):288–295. doi: 10.1002/art.38877
   PubMed Web of Science ®Google Scholar
• Cader MZ, Boroviak K, Zhang Q, et al. C13orf31 (FAMIN) is a central regulator of immunometabolic function [article]. Nat Immunol. 2016;17(9):1046–1056. doi: 10.1038/ni.3532
   PubMed Web of Science ®Google Scholar
• Patel N, El Mouzan MI, Al-Mayouf SM, et al. Study of mendelian forms of Crohn’s disease in Saudi Arabia reveals novel risk loci and alleles. Gut. 2014 Nov;63(11):1831–1832.
   PubMed Web of Science ®Google Scholar
• Butbul Aviel Y, Ofir A, Ben-Izhak O, et al. A novel loss-of-function mutation in LACC1 underlies hereditary juvenile arthritis with extended intra-familial phenotypic heterogeneity. Rheumatology (Oxford). 2021 Oct 2;60(10):4888–4898. doi: 10.1093/rheumatology/keab017
   PubMed Web of Science ®Google Scholar
• Omarjee O, Mathieu AL, Quiniou G, et al. LACC1 deficiency links juvenile arthritis with autophagy and metabolism in macrophages. J Exp Med. 2021 Mar 1;218(3). doi: 10.1084/jem.20201006
   PubMed Web of Science ®Google Scholar
• Kallinich T, Thorwarth A, von Stuckrad S-L, et al. Juvenile arthritis caused by a novel FAMIN (LACC1) mutation in two children with systemic and extended oligoarticular course [journal article]. Pediatr Rheumatol. 2016;14(1):63. doi: 10.1186/s12969-016-0124-2
   PubMedGoogle Scholar
• Huang Z, You X, Chen L, et al. mTORC1 links pathology in experimental models of still’s disease and macrophage activation syndrome. Nat Commun. 2022 Nov 28;13(1):6915. doi: 10.1038/s41467-022-34480-6
   PubMed Web of Science ®Google Scholar
• Wei Z, Oh J, Flavell RA, et al. LACC1 bridges NOS2 and polyamine metabolism in inflammatory macrophages. Nature. 2022 Sep;609(7926):348–353.
   PubMed Web of Science ®Google Scholar
• Manki A, Nishikomori R, Nakata-Hizume M, et al. Tumor necrosis factor receptor-associated periodic syndrome mimicking systemic juvenile idiopathic arthritis. Allergol Int. 2006 Sep;55(3):337–341.
   PubMedGoogle Scholar
• Horneff G, Rhouma A, Weber C, et al. Macrophage activation syndrome as the initial manifestation of tumour necrosis factor receptor 1-associated periodic syndrome (TRAPS). Clin Exp Rheumatol. 2013;31:S99–S102.
   PubMed Web of Science ®Google Scholar
• Ayaz NA, Ozen S, Bilginer Y, et al. MEFV mutations in systemic onset juvenile idiopathic arthritis. Rheumatology (Oxford). 2009 Jan;48(1):23–25.
   PubMed Web of Science ®Google Scholar
• Rigante D, Emmi G, Fastiggi M, et al. Macrophage activation syndrome in the course of monogenic autoinflammatory disorders [journal article]. Clin Rheumatol. 2015 Aug 01;34(8):1333–1339. doi: 10.1007/s10067-015-2923-0
   PubMed Web of Science ®Google Scholar
• Alansari S, Alsaleem A, Alzaid T, et al. The SLC29A3 variant, neutrophilic dermatosis, and hyperferritinemia imitate systemic juvenile idiopathic arthritis in a Saudi child: a case report. J Rheum Dis. 2023 Apr 1;30(2):133–137. doi: 10.4078/jrd.22.0054
   PubMedGoogle Scholar
• Molho-Pessach V, Ramot Y, Camille F, et al. H syndrome: the first 79 patients. J Am Acad Dermatol. 2014 Jan;70(1):80–88.
   PubMed Web of Science ®Google Scholar
• Jorgensen SE, Christiansen M, Host C, et al. Systemic juvenile idiopathic arthritis and recurrent macrophage activation syndrome due to a CASP1 variant causing inflammasome hyperactivation. Rheumatology (Oxford). 2020 Oct 1;59(10):3099–3105. doi: 10.1093/rheumatology/keaa242
   PubMed Web of Science ®Google Scholar
• Shimizu M, Nakagishi Y, Yachie A. Distinct subsets of patients with systemic juvenile idiopathic arthritis based on their cytokine profiles. Cytokine. 2013 Feb 01;61(2):345–348.
   PubMed Web of Science ®Google Scholar
• Weiss ES, Girard-Guyonvarc’h C, Holzinger D, et al. Interleukin-18 diagnostically distinguishes and pathogenically promotes human and murine macrophage activation syndrome. Blood. 2018;131(13):1442–1455. doi: 10.1182/blood-2017-12-820852
   PubMed Web of Science ®Google Scholar
• Yasin S, Fall N, Brown RA, et al. IL-18 as a biomarker linking systemic juvenile idiopathic arthritis and macrophage activation syndrome. Rheumatology (Oxford). 2020 Feb 1;59(2):361–366. doi: 10.1093/rheumatology/kez282
   PubMed Web of Science ®Google Scholar
• Schulert GS, Canna SW. Convergent pathways of the hyperferritinemic syndromes. Int Immunol. 2018 Apr 25;30(5):195–203.
   PubMed Web of Science ®Google Scholar
• Canna SW, de Jesus AA, Gouni S, et al. An activating NLRC4 inflammasome mutation causes autoinflammation with recurrent macrophage activation syndrome. Nat Genet. 2014 Oct;46(10):1140–1146. doi: 10.1038/ng.3089
   PubMed Web of Science ®Google Scholar
• Kitamura A, Sasaki Y, Abe T, et al. An inherited mutation in NLRC4 causes autoinflammation in human and mice. J Exp Med. 2014 Nov 17;211(12):2385–2396. doi: 10.1084/jem.20141091
   PubMed Web of Science ®Google Scholar
• Romberg N, Al Moussawi K, Nelson-Williams C, et al. Mutation of NLRC4 causes a syndrome of enterocolitis and autoinflammation. Nat Genet. 2014 Oct;46(10):1135–1139.
   PubMed Web of Science ®Google Scholar
• Gernez Y, de Jesus AA, Alsaleem H, et al. Severe autoinflammation in 4 patients with C-terminal variants in cell division control protein 42 homolog (CDC42) successfully treated with IL-1β inhibition. J Allergy Clin Immunol. 2019 Oct;144(4):1122–1125.e6.
   PubMed Web of Science ®Google Scholar
• Lam MT, Coppola S, Krumbach OHF, et al. A novel disorder involving dyshematopoiesis, inflammation, and HLH due to aberrant CDC42 function. J Exp Med. 2019 Dec 2;216(12):2778–2799. doi: 10.1084/jem.20190147
   PubMed Web of Science ®Google Scholar
• Wada T, Kanegane H, Ohta K, et al. Sustained elevation of serum interleukin-18 and its association with hemophagocytic lymphohistiocytosis in XIAP deficiency. Cytokine. 2014 Jan;65(1):74–78.
   PubMed Web of Science ®Google Scholar
• Marsh RA, Madden L, Kitchen BJ, et al. XIAP deficiency: a unique primary immunodeficiency best classified as X-linked familial hemophagocytic lymphohistiocytosis and not as X-linked lymphoproliferative disease. Blood. 2010 Aug 19;116(7):1079–1082. doi: 10.1182/blood-2010-01-256099
   PubMed Web of Science ®Google Scholar
• Rigaud S, Fondaneche MC, Lambert N, et al. XIAP deficiency in humans causes an X-linked lymphoproliferative syndrome. Nature. 2006 Nov 2;444(7115):110–114. doi: 10.1038/nature05257
   PubMed Web of Science ®Google Scholar
• Latour S, Aguilar C. XIAP deficiency syndrome in humans. Semin Cell Dev Biol. 2015 Mar;39:115–123. doi: 10.1016/j.semcdb.2015.01.015
   PubMed Web of Science ®Google Scholar
• Chau AS, Cole BL, Debley JS, et al. Heme oxygenase-1 deficiency presenting with interstitial lung disease and hemophagocytic flares. Pediatr Rheumatol Online J. 2020 Oct 16;18(1):80. doi: 10.1186/s12969-020-00474-1
   PubMed Web of Science ®Google Scholar
• Romberg N, Vogel TP, Canna SW. NLRC4 inflammasomopathies. Curr Opin Allergy Clin Immunol. 2017 Dec;17(6):398–404. doi: 10.1097/ACI.0000000000000396
   PubMed Web of Science ®Google Scholar
• Stone DL, Ombrello A, Arostegui JI, et al. Excess serum interleukin-18 distinguishes patients with pathogenic mutations in PSTPIP1. Arthritis Rheumatol. 2021 Sep 7;74:353–357.
   Web of Science ®Google Scholar
• FO DM, Doireau V, Faye A, et al. Intermittent hemophagocytic lymphohistiocytosis is a regular feature of lysinuric protein intolerance. J Pediatr. 1999;134(2):236–239. doi: 10.1016/S0022-3476(99)70423-3
   PubMed Web of Science ®Google Scholar
• Magg T, Okano T, Koenig LM, et al. Heterozygous OAS1 gain-of-function variants cause an autoinflammatory immunodeficiency. Sci Immunol. 2021 Jun 18;6(60). doi: 10.1126/sciimmunol.abf9564
   PubMed Web of Science ®Google Scholar
• Pardeo M, Rossi MN, Pires Marafon D, et al. Early treatment and IL1RN single-nucleotide polymorphisms affect response to Anakinra in systemic juvenile idiopathic arthritis. Arthritis Rheumatol. 2021 Jun;73(6):1053–1061.
   PubMed Web of Science ®Google Scholar
• Hinze C, Fuehner S, Kessel C, et al. Impact of IL1RN variants on response to interleukin-1 blocking therapy in systemic juvenile idiopathic arthritis. Arthritis Rheumatol. 2020 Mar;72(3):499–505.
   PubMed Web of Science ®Google Scholar
• Erkens RGA, Calis JJA, Verwoerd A, et al. Recombinant interleukin-1 receptor antagonist is an effective first-line treatment strategy in new-onset systemic juvenile idiopathic arthritis, irrespective of HLA-DRB1 background and IL1RN variants. Arthritis Rheumatol. 2023 Jul 20;76(1):119–129. doi: 10.1002/art.42656
   PubMed Web of Science ®Google Scholar
• Byrne RP, van Rheenen W, et al. Project Min EALSGC. Dutch population structure across space, time and GWAS design. Nat Commun. 2020 Sep 11;11(1):4556. doi: 10.1038/s41467-020-18418-4.
   PubMed Web of Science ®Google Scholar
• Kimura Y, Weiss JE, Haroldson KL, et al. Pulmonary hypertension and other potentially fatal pulmonary complications in systemic juvenile idiopathic arthritis. Arthritis Care Res. 2013 May;65(5):745–752.
   PubMed Web of Science ®Google Scholar
• Lerman AM, Mahmud SA, Alfath Z, et al. HLA – DRB1 *15 and eosinophilia are common among patients with systemic juvenile idiopathic arthritis. Arthritis Care Res. 2023 Apr 13;75(10):2082–2087. doi: 10.1002/acr.25132
   Web of Science ®Google Scholar
• Wobma H, Arvila SR, Taylor ML, et al. Incidence and risk factors for eosinophilia and lung disease in biologic-exposed children with systemic juvenile idiopathic arthritis. Arthritis Care Res. 2023 Apr 11;75(10):2063–2072. doi: 10.1002/acr.25129
   Web of Science ®Google Scholar
• Huang Y, Sompii-Montgomery L, Patti J, et al. Disease course, treatments, and outcomes of children with systemic juvenile idiopathic arthritis associated lung disease (SJIA-LD). Arthritis Care Res. 2023 Sep 10;76:328–339.
   Web of Science ®Google Scholar
• Bracaglia CP, Troiano M, Testa G, et al. HLA-DRB1*15 alleles in systemic juvenile idiopathic arthritis with lung disease and macrophage activation syndrome in Italy. Pediatr Rheumatol. 2023;21:306.
   Google Scholar
• Wobma H, Bachrach R, Farrell J, et al. Development of a screening algorithm for lung disease in systemic juvenile idiopathic arthritis. ACR Open Rheumatol. 2023 Oct;5(10):556–562.
   PubMedGoogle Scholar
• Towe C, Grom AA, Schulert GS. Diagnosis and management of the systemic juvenile idiopathic arthritis patient with emerging lung disease. Paediatr Drugs. 2023 Nov;25(6):649–658. doi: 10.1007/s40272-023-00593-8
   PubMed Web of Science ®Google Scholar
• Crayne CB, Albeituni S, Nichols KE, et al. The immunology of macrophage activation syndrome. Front Immunol. 2019;10:119. doi: 10.3389/fimmu.2019.00119
   PubMed Web of Science ®Google Scholar
• Schulert GS, Grom AA. Pathogenesis of macrophage activation syndrome and potential for cytokine- directed therapies. Annu Rev Med. 2015;66(1):145–159. doi: 10.1146/annurev-med-061813-012806
   PubMed Web of Science ®Google Scholar
• Emile JF, Abla O, Fraitag S, et al. Revised classification of histiocytoses and neoplasms of the macrophage-dendritic cell lineages. Blood. 2016 Jun 2;127(22):2672–2681. doi: 10.1182/blood-2016-01-690636
   PubMed Web of Science ®Google Scholar
• Nikiforow S, Berliner N. To “lump” or to “split” in macrophage activation syndrome and hemophagocytic lymphohistiocytosis. Arthritis Rheumatol. 2020 Feb;72(2):206–209. doi: 10.1002/art.41106
   PubMed Web of Science ®Google Scholar
• Bracaglia C, Prencipe G, De Benedetti F. Macrophage activation syndrome: different mechanisms leading to a one clinical syndrome. Pediatr Rheumatol Online J. 2017 Jan 17;15(1):5.
   PubMed Web of Science ®Google Scholar
• Carter SJ, Tattersall RS, Ramanan AV. Macrophage activation syndrome in adults: recent advances in pathophysiology, diagnosis and treatment. Rheumatology (Oxford). 2019 Jan 1;58(1):5–17.
   PubMed Web of Science ®Google Scholar
• Schulert GS, Cron RQ. The genetics of macrophage activation syndrome. Genes Immunity. 2020 May;21(3):169–181. doi: 10.1038/s41435-020-0098-4
   PubMed Web of Science ®Google Scholar
• Jenkins MR, Rudd-Schmidt JA, Lopez JA, et al. Failed CTL/NK cell killing and cytokine hypersecretion are directly linked through prolonged synapse time. J Exp Med. 2015 Mar 9;212(3):307–317. doi: 10.1084/jem.20140964
   PubMed Web of Science ®Google Scholar
• Zhang M, Bracaglia C, Prencipe G, et al. A heterozygous RAB27A mutation associated with delayed cytolytic granule polarization and Hemophagocytic Lymphohistiocytosis. J Immunol. 2016 Mar 15;196(6):2492–2503. doi: 10.4049/jimmunol.1501284
   PubMed Web of Science ®Google Scholar
• Stepp SE, Dufourcq-Lagelouse R, Deist FL, et al. Perforin gene defects in familial hemophagocytic lymphohistiocytosis. Science. 1999;286:1957–1959. doi: 10.1126/science.286.5446.1957
   PubMed Web of Science ®Google Scholar
• Janka GE. Familial and acquired hemophagocytic lymphohistiocytosis. Annu Rev Med. 2012;63(1):233–246. doi: 10.1146/annurev-med-041610-134208
   PubMedGoogle Scholar
• Vastert SJ, van Wijk R, D’Urbano LE, et al. Mutations in the perforin gene can be linked to macrophage activation syndrome in patients with systemic onset juvenile idiopathic arthritis. Rheumatology (Oxford). 2010 Mar;49(3):441–449.
   PubMed Web of Science ®Google Scholar
• Zhang K, Biroschak J, Glass DN, et al. Macrophage activation syndrome in patients with systemic juvenile idiopathic arthritis is associated with MUNC13-4 polymorphisms. Arthritis Rheum. 2008 Sep;58(9):2892–2896.
   PubMed Web of Science ®Google Scholar
• Hazen MM, Woodward AL, Hofmann I, et al. Mutations of the hemophagocytic lymphohistiocytosis-associated gene UNC13D in a patient with systemic juvenile idiopathic arthritis. Arthritis Rheum. 2008 Feb;58(2):567–570.
   PubMed Web of Science ®Google Scholar
• Zhang M, Behrens EM, Atkinson TP, et al. Genetic defects in cytolysis in macrophage activation syndrome. Curr Rheumatol Rep. 2014;16(9):439. doi: 10.1007/s11926-014-0439-2
   PubMed Web of Science ®Google Scholar
• Schulert GS, Zhang M, Husami A, et al. Brief report: novel UNC13D intronic variant disrupting an NF-kappaB Enhancer in a patient with recurrent macrophage activation syndrome and systemic juvenile idiopathic arthritis. Arthritis Rheumatol. 2018 Jun;70(6):963–970.
   PubMed Web of Science ®Google Scholar
• Zhang K, Jordan MB, Marsh RA, et al. Hypomorphic mutations in PRF1, MUNC13-4, and STXBP2 are associated with adult-onset familial HLH. Blood. 2011 Nov 24;118(22):5794–5798. doi: 10.1182/blood-2011-07-370148
   PubMed Web of Science ®Google Scholar
• Kaufman KM, Linghu B, Szustakowski JD, et al. Whole-exome sequencing reveals overlap between macrophage activation syndrome in systemic juvenile idiopathic arthritis and familial hemophagocytic lymphohistiocytosis. Arthritis Rheumatol. 2014 Dec;66(12):3486–3495. doi: 10.1002/art.38793
   PubMed Web of Science ®Google Scholar
• Canna SW, Behrens EM. Making sense of the cytokine storm: a conceptual framework for understanding, diagnosing, and treating hemophagocytic syndromes. Pediatr Clin North Am. 2012 Apr;59(2):329–344. doi: 10.1016/j.pcl.2012.03.002
   PubMed Web of Science ®Google Scholar
• Risma K, Jordan MB. Hemophagocytic lymphohistiocytosis: updates and evolving concepts. Curr Opin Pediatr. 2012 Feb;24(1):9–15. doi: 10.1097/MOP.0b013e32834ec9c1
   PubMed Web of Science ®Google Scholar
• Strippoli R, Caiello I, De Benedetti F. Reaching the threshold: a multilayer pathogenesis of macrophage activation syndrome. J Rheumatol. 2013 Jun;40(6):761–767. doi: 10.3899/jrheum.121233
   PubMed Web of Science ®Google Scholar
• Petralia F, Tignor N, Reva B, et al. Integrated proteogenomic characterization across Major histological types of pediatric brain cancer. Cell. 2020 Dec 23;183(7):1962–1985 e31. doi: 10.1016/j.cell.2020.10.044
   PubMed Web of Science ®Google Scholar
• Rodriguez H, Zenklusen JC, Staudt LM, et al. The next horizon in precision oncology: proteogenomics to inform cancer diagnosis and treatment. Cell. 2021 Apr 1;184(7):1661–1670. doi: 10.1016/j.cell.2021.02.055
   PubMed Web of Science ®Google Scholar
• Uffelmann E, Huang QQ, Munung NS, et al. Genome-wide association studies. Nat Rev Dis Primers. 2021;1(1). doi: 10.1038/s43586-021-00056-9
   Google Scholar
• Jia X, Tan L, Chen S, et al. Monogenic lupus: tracing the therapeutic implications from single gene mutations. Clin Immunol. 2023 Sep;254:109699. doi: 10.1016/j.clim.2023.109699
   PubMed Web of Science ®Google Scholar
• Omarjee O, Picard C, Frachette C, et al. Monogenic lupus: Dissecting heterogeneity. Autoimmun Rev. 2019 Oct;18(10):102361.
   PubMed Web of Science ®Google Scholar